4,4,5,5,5-Pentafluoro-1-Pentanol Bulk Price 2026: Market Outlook & Sourcing Strategy
- Anticipated 2026 bulk prices for 4,4,5,5,5-Pentafluoro-1-pentanol reflect tightening supply and rising demand in fluorinated pharmaceutical intermediates.
- Industrial purity (≥98%) and consistent COA documentation are critical for GMP-compliant API synthesis routes.
- NINGBO INNO PHARMCHEM CO.,LTD. offers scalable production capacity and transparent pricing for multi-kilogram to metric-ton orders.
As the pharmaceutical and agrochemical sectors intensify their adoption of fluorinated building blocks, 4,4,5,5,5-Pentafluoro-1-pentanol (CAS 148043-73-6) has emerged as a strategically valuable intermediate. With its unique perfluorinated terminal structure and primary alcohol functionality, this compound enables efficient synthesis of bioactive molecules requiring enhanced metabolic stability and lipophilicity. For procurement teams planning 2026 budgets, understanding current and projected bulk price dynamics is essential to secure cost-effective, reliable supply chains.
Current Bulk Pricing Trends for 4,4,5,5,5-Pentafluoro-1-pentanol
As of late 2024 and early 2025, the global market for 4,4,5,5,5-pentafluoropentanol shows steady upward pressure on pricing, driven by constrained raw material availability and increased regulatory scrutiny on fluorination processes. While small-scale lab quantities (e.g., 5 g at ≥93% purity) remain accessible through catalog suppliers, industrial buyers require significantly higher volumes—typically starting at 10 kg—with stringent quality controls.
For bulk orders (≥25 kg), current FOB China pricing ranges between USD 1,800–2,400/kg, depending on purity tier, packaging, and delivery terms. However, projections for 2026 indicate a potential 8–12% increase due to:
- Rising costs of fluorochemical precursors (e.g., pentafluoropropylene oxide)
- Stricter environmental compliance in fluorination manufacturing
- Growing demand from peptide mimetic and kinase inhibitor programs
Crucially, not all suppliers can guarantee consistent industrial purity above 98%—a threshold often mandated for advanced pharmaceutical synthesis. Impurities such as residual solvents or partially fluorinated alcohols can derail downstream reactions, making vendor qualification non-negotiable.
Factors Influencing Industrial-Scale Pricing in 2026
The synthesis route employed by the manufacturer directly impacts both cost and scalability. The most efficient industrial pathway involves nucleophilic ring-opening of hexafluoropropylene oxide (HFPO) followed by controlled reduction—a process requiring specialized corrosion-resistant reactors and rigorous moisture control. Manufacturers lacking integrated fluorochemistry expertise often face yield losses (>15%) and batch-to-batch variability, which they offset through premium pricing.
In contrast, vertically integrated producers like NINGBO INNO PHARMCHEM CO.,LTD. leverage in-house HFPO handling capabilities and optimized workups to achieve yields exceeding 85% with >98.5% GC purity. This efficiency translates into more stable 2026 bulk price forecasts for qualified partners.
Another key variable is documentation rigor. Reputable buyers consistently request full analytical packages, including COA (Certificate of Analysis) with NMR, GC, water content (KF), and residual metal data. Suppliers unable to provide batch-specific COAs often signal inadequate QC infrastructure—a red flag for regulated applications.
When sourcing high-purity manufacturing process materials, buyers should prioritize vendors with ISO 9001-certified facilities and experience supporting FDA/EMA filings.
2026 Bulk Price Projection Table (FOB China)
| Order Volume | Current Purity Standard | 2025 Avg. Price (USD/kg) | 2026 Projected Price (USD/kg) | Certifications Included |
|---|---|---|---|---|
| 10–25 kg | ≥97% (GC) | 2,200–2,600 | 2,400–2,850 | COA, SDS, TSE/BSE Statement |
| 50–100 kg | ≥98% (GC) | 1,900–2,200 | 2,050–2,400 | Full COA + NMR, ISO 9001 |
| 200+ kg | ≥98.5% (GC) | 1,600–1,900 | 1,750–2,100 | GMP-supporting docs, Audit-ready |
How to Request Custom Quotes from Global Manufacturers
Given the niche nature of Pentafluoropentanol, off-the-shelf e-commerce pricing rarely reflects true industrial economics. Instead, strategic buyers engage directly with qualified global manufacturers for tailored quotations. To streamline this process:
- Specify exact technical requirements: Include target purity (e.g., ≥98.5% by GC), acceptable impurity thresholds, packaging (e.g., nitrogen-purged HDPE drums), and required documentation.
- Request batch-specific COA samples: Evaluate analytical rigor before committing to volume.
- Assess scalability: Confirm the supplier’s ability to deliver multi-hundred-kilogram batches without re-optimization delays.
NINGBO INNO PHARMCHEM CO.,LTD. stands out as a premier source for 4,4,5,5,5-Pentafluoro-1-pentanol, combining deep fluoroorganic expertise with agile production scheduling. Their dedicated team provides rapid-response quotes inclusive of lead time, regulatory support letters, and sample availability—critical for de-risking 2026 procurement plans.
For R&D and commercial teams advancing fluorinated APIs, securing a reliable partner now ensures both cost predictability and supply continuity as market dynamics evolve into 2026 and beyond.